Bradley Parry, PhD

Chief Technology Officer at AI Therapeutics

Bradley Parry, PhD has a diverse work experience. In 2019, they were appointed as the Head of Artificial Intelligence at AI Therapeutics. Prior to that, from 2015 to 2019, they were a Post-doctoral associate at Yale University and the Howard Hughes Medical Institute. During their time there, they designed and implemented a range of experimental and novel computational approaches to study dynamical properties of the bacterial cytoplasm, which involved development of de novo image processing routines merged with development of statistical inference/deep learning methods to analyze resulting data sets.

Bradley Parry, PhD attained their Doctor of Philosophy (Ph.D.) from Yale University in 2015, where they studied MCDB - biology & physics. Bradley also earned a Master's Degree from Rutgers University - Camden in 2009, where they studied Molecular Biology & Bioinformatics.

Links

Previous companies

Yale University logo

Org chart